Ginkgo Bioworks (DNA) Misses Q4 EPS by 1c

Ginkgo Bioworks (NYSE: DNA) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $34.76 million versus the consensus estimate of $42.5 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Cargojet Inc. (CJT:CN) (CGGJF) PT Raised to $128 at TD Cowen, maintains bullish call
• Empress Royalty acquires Tongon gold stream for $62M